Philip Peng MBBS FRCPC - PowerPoint PPT Presentation

1 / 33
About This Presentation
Title:

Philip Peng MBBS FRCPC

Description:

Director of Research, Wasser Pain Management Center, Mount ... cyclobenzaprine. estradiol. fluvoxamine. haloperidol. imipramine N-DeMe. mexiletine. naproxen ... – PowerPoint PPT presentation

Number of Views:71
Avg rating:3.0/5.0
Slides: 34
Provided by: t68s
Category:

less

Transcript and Presenter's Notes

Title: Philip Peng MBBS FRCPC


1
Management of Methadone patients in APS
  • Philip Peng MBBS FRCPC
  • Director, Anesthesia Chronic Pain Program,
  • University Health Network
  • Director of Research, Wasser Pain Management
    Center, Mount Sinai Hospital

2
Objective
  • Discussion of the relevant pharmacology of
    methadone
  • License requirement of methadone in Canada
  • Suggested algorithm for management of methadone
    patients in APS

3
Who wants to be a millionaire
  • Which of the following is a true long-acting
    opioid?
  • A Fentanyl patch
  • B MS Contin
  • D Marijuana
  • C Methadone

4
Opioids
Elimination half-life
Short-acting
Long acting E.g. methadone, buprenorphine
Sustain release
Immediate release
5
Methadone
Synthetic opioid, structure very different from
other opioid
methadone
codeine
morphine
6
Basic pharmacology
  • HCl powder, formulated as liquid (PO, rectal,
    parenteral)
  • Tablets form available
  • Racemic mixture of 2 enantiomers
  • R-Met opioid agonist
  • S-Met NMDA antagonist ? reuptake of 5HT and NA

? tolerance Neuropathic pain
7
Basic pharmacology
  • Excellent PO bioavailability (85)
  • Onset in 30 min., peak level in 2.5 h
  • Biphasic elimination

8
analgesia (? elimination 8-12 h)
maintenance (? elimination 30-60 h)
Plasma level
Time
9
Methadone License in Canada
  • A controlled substance, prescription required
    exemptions (Section 56 under Controlled Drugs and
    Substances Act)
  • Two types of exemptions
  • MMT-provincial medial authorities
  • Pain Federal Office of Controlled Substances
    except BC, Quebec, Alberta and Manitoba
  • Emergency situation
  • Temporary license which is MD-, patient- and
    institution-specific and expires on D/C or after
    2 months.

10
  • Kim Barber B. Pharm.
  • Scientific Officer
  • Methadone Program
  • Office of Controlled Substances
  • Kim_Barber_at_hc-sc.gc.ca
  • Phone (613) 946-5139
  • Fax (613) 952-2196

11
Methadone license exemption for pain in Canada
12
Problem with methadone
  • Drug interaction
  • Single dose overdose
  • Accumulated toxicity

13
Problem with methadone
  • Drug interaction
  • Single dose overdose
  • Accumulated toxicity

14
Drug interaction
  • Methadone EDDP

N-demethylation
Cytochrome system CYP 3A4, 2D6, 1A2
carvedilolS-metoprololpropafenonetimolola
mitriptyline  clomipramine  desipramineimiprami
ne  paroxetine haloperidolperphenazinerisperi
done thioridazinealprenololamphetaminebufuralo
lchlorpheniraminechlorpromazinecodeine
debrisoquine
amitriptylinecaffeineclomipramineclozapinecycl
obenzaprineestradiolfluvoxaminehaloperidolimip
ramine N-DeMemexiletinenaproxen  ondansetron
 phenacetingtacetaminophengtNAPQIpropranololri
luzoleropivacainetacrinetheophyllineverapamil
 (R)warfarinzileutonzolmitriptan
dexfenfluraminedextromethorphanencainideflecain
idefluoxetinefluvoxaminelidocaine
 metoclopramidemethoxyamphetaminemexiletinenor
triptylineminaprineondansetronperhexilinephena
cetinphenforminpropranolol  quanoxansparteine
tamoxifentramadolvenlafaxine
15
Cytochrome drug interaction
16
Other mechanisms of drug interaction
  • ?1-acid glycoprotein
  • Circulating level ? with stress, addiction,
    cancer and drugs such as amitriptylline
  • Pharmacodynamics interaction

benzodiazepine
Excitatory NMDA
Inhibitory GABA
Respiration rhythm
methadone
17
Other mechanisms of drug interaction
  • ?1-acid glycoprotein
  • Circulating level ? with stress, addiction,
    cancer and drugs such as amitriptylline
  • Pharmacodynamics interaction

Excitatory NMDA
Inhibitory GABA
Respiration rhythm
18
Other mechanisms of drug interaction
  • ?1-acid glycoprotein
  • Circulating level ? with stress, addiction,
    cancer and drugs such as amitriptylline
  • Pharmacodynamics interaction

Excitatory NMDA
Inhibitory GABA
Respiration rhythm
19
Problem with methadone
  • Drug interaction
  • Single dose overdose
  • Accumulated toxicity

20
Single dose Overdose
Problem mg vs ml
21
Problem with methadone
  • Drug interaction
  • Single dose overdose
  • Accumulated toxicity

22
Accumulated toxicity
  • Over-aggressive titration of methadone dose

23
Algorithm of managing methadone patients in APS
  • Elective surgery

In-patient surgery NPO lt48h
In-patient surgery NPO gt48h
Day surgery
24
Algorithm of managing methadone patients in APS
  • Elective surgery

  • Pre-operative anesthesia consult
  • Continue methadone until the day of surgery
  • Pre-operative ECG
  • Bring their own methadone

25
Continue methadone until the day of surgery
26
Algorithm of managing methadone patients in APS
  • Elective surgery

In-patient surgery NPO lt48h
In-patient surgery NPO gt48h
Day surgery
  • Resume regular dose of methadone after surgery
  • Additional analgesic for pain control

27
Algorithm of managing methadone patients in APS
  • Elective surgery

In-patient surgery NPO lt48h
In-patient surgery NPO gt48h
Day surgery
  • While NPO, alternative analgesic e.g. PCA
  • Resume methadone ASAP PO well

28
Algorithm of managing methadone patients in APS
  • Elective surgery

In-patient surgery NPO lt48h
In-patient surgery NPO gt48h
Day surgery
  • While NPO, consider PCA /- infusion
  • Drug-drug interaction
  • Resume methadone ASAP PO well

29
PCA with infusion
  • Does not improve analgesia or sleep
  • Increase opioids consumption and risk of SE

30
Case presentation
  • 34 y.o. man on methadone via MMT and is coming
    for knee arthroscopic surgery.
  • 65 y.o. lady , currently on methadone for her
    pain related to rheumatoid arthritis, is
    scheduled for total hip replacement
  • 45 y.o. lady, on methadone for metastatic breast
    cancer, is admitted for bowel resection.

31
Case presentation
  • 34 y.o. man on methadone via MMT and is coming
    for knee arthroscopic surgery.
  • 65 y.o. lady , currently on methadone for her
    pain related to rheumatoid arthritis, is
    scheduled for total hip replacement
  • 45 y.o. lady, on methadone for metastatic breast
    cancer, is admitted for bowel resection.

32
Case presentation
  • 34 y.o. man on methadone via MMT and is coming
    for knee arthroscopic surgery.
  • 65 y.o. lady , currently on methadone for her
    pain related to rheumatoid arthritis, is
    scheduled for total hip replacement
  • 45 y.o. lady, on methadone for metastatic breast
    cancer, is admitted for bowel resection.

33
Case presentation
  • 34 y.o. man on methadone via MMT and is coming
    for knee arthroscopic surgery.
  • 65 y.o. lady , currently on methadone for her
    pain related to rheumatoid arthritis, is
    scheduled for total hip replacement
  • 45 y.o. lady, on methadone for metastatic breast
    cancer, is admitted for bowel resection.
Write a Comment
User Comments (0)
About PowerShow.com